Neuroprotective effect of riluzole in MPTP-treated mice
- 4 September 2001
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 918 (1-2) , 176-181
- https://doi.org/10.1016/s0006-8993(01)02944-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouseEuropean Journal of Pharmaceutical Sciences, 2000
- Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey modelEuropean Journal of Pharmacology, 1998
- Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot studyEuropean Journal of Pharmacology, 1995
- Riluzole and experimental parkinsonismNeuroReport, 1994
- Riluzole and experimental parkinsonismNeuroReport, 1994
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- NMDA antagonists partially protect against MPTP induced neurotoxicity in miceNeuroReport, 1993
- 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—II Biochemical propertiesNeuropharmacology, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984